Delivery Order SPE2DB24D2106-SPE2DB26FATWR
- Not listed
- The Defense Logistics Agency awarded a $17.8K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jardiance 25 mg tablets (90-count units). The delivery order, issued on April 21, 2025, with an ultimate completion date of April 22, 2025, carries no set-aside designation. This award represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier...
- The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Jardiance 25 mg tablets. The order has a potential value of $4,094.64 and is set to be completed by February 9, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that holds an indefinite delivery contract with the Defense Logistics Agency, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $30,010.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jardiance 10 mg tablets in quantities of 90. The contract employs a firm fixed-price structure with an ultimate completion date of September 12, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4.7 million to DMS Pharmaceutical Group Inc. for 90-count tablets of Jardiance 25 mg, a diabetes medication. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $18,413.70 for 90-count tablets of Jardiance 25 mg on August 18, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is headquartered. Jardiance is a prescription medication commonly prescribed for type 2...
- This delivery order, valued at $3,723.43, was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. for the supply of Jardiance 25 mg tablets in quantities of 90 units. The award, executed on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price contract with no set-aside designation. Performance of this order will occur at the vendor's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small...
- The Defense Logistics Agency awarded a delivery order valued at $10,772.99 to DMS Pharmaceutical Group Inc. for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price delivery order, issued on September 15, 2025, represents fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract carries no set-aside designation. Performance will be completed by September 16, 2025, with the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,162.08 to DMS Pharmaceutical Group Inc. for the supply of Jardiance 25 mg tablets (90-count packages). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform delivery to Conshohocken, Pennsylvania by the August 22, 2025 completion date. This delivery order was awarded without set-aside designation and represents a continuation of DMS...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,808.24 to DMS Pharmaceutical Group Inc. for 90-count tablets of Jardiance 25 mg, with an ultimate completion date of May 28, 2025. The award was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, Illinois. The company has been registered in the System...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,255.70 by the Defense Logistics Agency (DLA) on April 24, 2025. The contract calls for the supply of Jardiance 10 mg tablets in a 90-count package, with completion scheduled for April 25, 2025. This delivery order was issued without a set-aside designation and is performed at the contractor's facility in Park Ridge,...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB26FATWRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,686.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jardiance 25 mg tablets (90-count units). The delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a firm fixed-price contract with no set-aside designation. Performance will be executed at the company's facility in Conshohocken, Pennsylvania. This award is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a multi-billion dollar acquisition strategy designed to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial federal contracting capability through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, with a product portfolio spanning branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company's prime vendor contract under PPV-G GEN V, awarded on November 13, 2025, carries a ceiling value of $499,999,999 with an ultimate completion date of December 31, 2036, positioning the company as a critical supplier for military healthcare operations globally. This delivery order for Jardiance exemplifies the routine pharmaceutical fulfillment executed under the broader prime vendor framework, supporting the Defense Logistics Agency's mission to ensure reliable pharmaceutical supply to Department of Defense medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 10/20/25 |